Transplantation Market - Forecast(2024 - 2030)

Report Code: HCR 1533 Report Format: PDF + Excel

Transplantation Market Overview:

The Transplantation Market is expected to grow at a CAGR of 10.10% , the market value projected to increase is from US $13180.56 Million in 2022 to US $28,459.80 Million by 2030

Transplantation market was a significant segment within the healthcare industry. It primarily encompassed organ and tissue transplantation procedures, including heart, liver, kidney, lung, pancreas, and bone marrow transplants. Transplantation is a life-saving treatment option for patients suffering from end-stage organ failure, severe tissue damage, or certain genetic disorders.

Advancements in Transplantation Techniques: Medical advancements and innovations in surgical techniques, immunosuppressive drugs, and organ preservation methods have improved the success rates of transplantation procedures. These advancements have contributed to increased patient outcomes and better post-transplantation care.

Ethical and Legal Issues: The transplantation market has also faced challenges related to ethical and legal concerns, such as organ trafficking and illegal transplantation practices. Governments and organizations worldwide have been working to combat these issues and promote ethical transplantation practices.

Market Snapshot: 

Transplantation Market- Report Coverage:
The “Transplantation Market Report - Forecast (2023-2030)” by IndustryARC, covers an in-depth analysis of the following segments in the Transplantation Market.




By Product Type

  • Tissue Products

  • Immunosuppressive Drugs

  • Preservation Solution

  • Others

By Application

  • Organ Transplantation

  • Tissue Transplantation

  • Others


By End Use

  • Transplant Centers

  • Hospitals

  • Other Conditions




By Geography

  • North America

  • Europe

  • Asia-Pacific

  • Middle-East and Africa, and

  • South America

  • Others 

Transplantation Market- Top Trends:

Technological Advancements: The transplantation field was benefiting from significant technological advancements, such as improved organ preservation techniques, minimally invasive surgical procedures, and better diagnostic tools for organ compatibility and rejection monitoring.

Increasing Organ Transplants: There was a growing demand for organ transplants due to an aging population, rising prevalence of chronic diseases, and an increased awareness of transplantation as a viable treatment option. This demand led to a rise in both deceased and living donor transplant procedures. 

Regenerative Medicine: Researchers and companies were investing in regenerative medicine techniques to create artificial organs and tissues. This emerging field has the potential to revolutionize transplantation by reducing the dependency on donor organs and eliminating the need for immunosuppressant drugs.

Organ Preservation Solutions: Improvements in organ preservation solutions, such as machine perfusion and cryopreservation techniques, were enabling better transportation and preservation of organs, increasing the chances of successful transplants.

Immunomodulation Therapies: Advancements in immunomodulation therapies were being explored to address the issue of organ rejection more effectively and reduce the need for lifelong immunosuppressive medications, which can have significant side effects.

The Transplantation Market- Company Analysis

Novartis AG: A Swiss multinational pharmaceutical company known for developing and manufacturing a wide range of pharmaceutical products. 

Pfizer Inc.: An American multinational pharmaceutical corporation recognized for its extensive contributions to the healthcare industry, including vaccines, medications, and consumer health products.

Sanofi: A French multinational pharmaceutical company engaged in research, development, manufacturing, and marketing of pharmaceutical products, vaccines, and healthcare solutions.

AbbVie Inc.: An American biopharmaceutical company primarily focusing on the development of drugs for various therapeutic areas, such as immunology, oncology, and neuroscience.

Johnson & Johnson: An American multinational corporation operating in various sectors, including pharmaceuticals, medical devices, and consumer goods.

Key Market Players: 

Product/Service launches, approvals, patents and events, acquisitions, partnerships, and collaborations are key strategies adopted by players in the Transplantation Market Report. The top 10 companies in this industry are listed below:

  1. Novartis AG
  2. Pfizer Inc.
  3. Sanofi
  4. AbbVie Inc.
  5. Johnson & Johnson
  6. Bristol-Myers Squibb Company
  7. Astellas Pharma Inc.
  8. Merck & Co., Inc.
  9. GlaxoSmithKline plc (GSK)
  10. Celgene Corporation (acquired by Bristol-Myers Squibb)

Scope of Report: 

Report Metric


Base Year Considered


Forecast Period

2022 – 2030


10.10 %

Market Size in 2030

28,459.80 Million

Segments Covered

By Type, By Treatment, By Condition, By Geography

Geographies Covered

  • North America

  • Europe

  • Asia-Pacific

  • Middle-East and Africa

  • South America

  • Others

Key Market Players

  1. Celgene Corporation 

  2. Roche Holding AG

  3. Takeda Pharmaceutical Company Limited

  4. AstraZeneca plc

  5. Amgen Inc.

  6. Gilead Sciences, Inc.

  7. Baxter International Inc.

  8. Bayer AG

  9. Biogen Inc.

  10. Vertex Pharmaceuticals Incorporated

For more Lifesciences and Healthcare Market reports, please click here
1. Transplantation Market - Overview
    1.1 Definitions and Scope
2. Transplantation Market - Executive Summary
3. Transplantation Market - Comparative Analysis
    3.1.Company Benchmarking - Key Companies
    3.2.Global Financial Analysis - Key Companies
    3.3.Market Share Analysis - Key Companies
    3.4.Patent Analysis
    3.5.Pricing Analysis
4. Transplantation Market - Start-up Companies Scenario (Premium)
    4.1. Key Start-up Company Analysis by
        4.1.1. Investment
        4.1.2. Revenue
        4.1.3. Venture Capital and Funding Scenario
5. Transplantation Market – Market Entry Scenario Premium (Premium)
   5.1. Regulatory Framework Overview
   5.2. New Business and Ease of Doing Business Index
   5.3. Case Studies of Successful Ventures
6. Transplantation Market - Forces
    6.1. Market Drivers
    6.2. Market Constraints
    6.3. Market Challenges
    6.4. Porter's Five Force Model
        6.4.1. Bargaining Power of Suppliers
        6.4.2. Bargaining Powers of Customers
        6.4.3. Threat of New Entrants
        6.4.4. Rivalry Among Existing Players
        6.4.5. Threat of Substitutes
7. Transplantation Market – Strategic Analysis
    7.1. Value Chain Analysis
    7.2. Opportunities Analysis
    7.3. Market Life Cycle
8. Transplantation Market   – By Product Type
    8.1. Tissue Products
        8.1.1 Market Trends by Region
        8.1.2 Market Share & Forecast by Region
    8.2. Immunosuppressive Drugs
        8.2.1 Market Trends by Region
        8.2.2 Market Share & Forecast by Region
    8.3. Preservation Solution
        8.3.1 Market Trends by Region
        8.3.2 Market Share & Forecast by Region
    8.4. Others
        8.4.1 Market Trends by Region
        8.4.2 Market Share & Forecast by Region
9. Transplantation Market –  By Application
    9.1 Tissue Transplantation
        9.1.1 Market Trends by Region
        9.1.2 Market Share & Forecast by Region
9.2 Others
    9.2.1 Market Trends by Region
    9.2.2 Market Share & Forecast by Region
10 Transplantation Market – by End-Use (Market Size – $Million/$Billion) 
    10.1 Transplant Centers,
        10.1.1 Market Trends by Region
        10.1.2 Market Share & Forecast by Region
10.2 Hospitals
    10.2.1 Market Trends by Region
    10.2.2 Market Share & Forecast by Region
10.3 Others Conditions
    10.3.1 Market Trends by Region
    10.3.2 Market Share & Forecast by Region
11 Transplantation Market  – by Geography (Market Size – $Million/$Billion) 
    11.1 North America
        11.1.1 The U.S.
        11.1.2 Canada
    11.2 Europe
        11.2.1 UK
        11.2.2 Germany
        11.2.3 France
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Russia
        11.2.7 Rest of Europe
    11.3 Asia-Pacific
        11.3.1 China
        11.3.2 India
        11.3.3 Japan
        11.3.4 South Korea
        11.3.5 Australia & New Zealand
        11.3.6 Rest of Asia-Pacific
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Chile
        11.4.4 Colombia
        11.4.5 Rest of South America
    11.5 Rest of the World
        11.5.1 Middle East
        11.5.2 Africa
12  Transplantation Market – Entropy
13  Transplantation Market - Industry/Segment Competition Landscape Premium 
    13.1 Market Share Analysis
        13.1.1 Market Share by Product Type – Key Companies
        13.1.2 Market Share by Region – Key Companies
        13.1.3 Market Share by Country – Key Companies
    13.2 Competition Matrix
    13.3 Best Practices for Companies
14 Transplantation Market – Key Company List by Country Premium Premium 
15 Transplantation Market - Company Analysis
    15.1 Novartis AG
    15.2 Pfizer Inc.
    15.3 Sanofi
    15.4 AbbVie Inc.
    15.5 Johnson & Johnson
    15.6 Bristol-Myers Squibb Company
    15.7 Astellas Pharma Inc.
    15.8 Merck & Co., Inc.
    15.9 GlaxoSmithKline plc (GSK)
    15.10 Celgene Corporation (acquired by Bristol-Myers Squibb)
    15.11 Roche Holding AG
    15.12 Takeda Pharmaceutical Company Limited
    15.13 AstraZeneca plc
    15.14 Amgen Inc.
    15.15 Gilead Sciences, Inc.
    15.16 Baxter International Inc.
    15.17 Bayer AG
    15.18 Biogen Inc.
    15.19 Vertex Pharmaceuticals Incorporated
    15.20 Roche Holding AG
"Financials to the Private Companies would be provided on best-effort basis."
Connect with our experts to get customized reports that best suit your requirements. Our 
reports include global-level data, niche markets and competitive landscape.

The Transplantation Market is projected to grow at 10.10% CAGR during the forecast period 2023-2030.

The Fox Nuts Market size is estimated to be US$28,459.80 Million in 2030.

Novartis AG, Pfizer Inc.,Sanofi , AbbVie Inc. , Johnson & Johnson, Bristol-Myers Squibb Company , Astellas Pharma Inc., Merck & Co., Inc., GlaxoSmithKline plc (GSK) ,Celgene Corporation (acquired by Bristol-Myers Squibb)